Khalil is a Managing Director at Invus, a New York-based global investment firm.

He joined Invus in 2003 and established the Public Equity Group, which he helms globally. Invus Public Equity focuses its investments on emerging innovative biotech companies. In addition to managing the Public Equity team, Khalil co-manages private biotech investments. He is a member of the board of ElevateBio, Sensorion, Onxeo, Protagenic Therapeutics, and Orthobond.

Prior to joining Invus, he worked at The Olayan Group in New York, where he ran their U.S. equity portfolio for 15 years.

As part of his philanthropic engagements, Khalil serves on the Board of the Children of Armenia Fund, LIFE Lebanon, and Solving Kids’ Cancer.

He holds a BA in Economics from the American University of Beirut.